166 related articles for article (PubMed ID: 26372607)
1. A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery.
Kilbaugh TJ; Himebauch AS; Zaoutis T; Jobes D; Greeley WJ; Nicolson SC; Zuppa AF
Paediatr Anaesth; 2015 Nov; 25(11):1111-9. PubMed ID: 26372607
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.
Himebauch AS; Nicolson SC; Sisko M; Moorthy G; Fuller S; Gaynor JW; Zuppa AF; Fox E; Kilbaugh TJ
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2634-41. PubMed ID: 25131168
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle and plasma concentrations of cefazolin during complex paediatric spinal surgery.
Himebauch AS; Sankar WN; Flynn JM; Sisko MT; Moorthy GS; Gerber JS; Zuppa AF; Fox E; Dormans JP; Kilbaugh TJ
Br J Anaesth; 2016 Jul; 117(1):87-94. PubMed ID: 27317707
[TBL] [Abstract][Full Text] [Related]
4. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest.
Caffarelli AD; Holden JP; Baron EJ; Lemmens HJ; D'Souza H; Yau V; Olcott C; Reitz BA; Miller DC; van der Starre PJ
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1338-43. PubMed ID: 16733167
[TBL] [Abstract][Full Text] [Related]
5. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
[TBL] [Abstract][Full Text] [Related]
6. A pilot study to determine the feasibility of continuous cefazolin infusion.
Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S
Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694
[TBL] [Abstract][Full Text] [Related]
7. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.
Brill MJ; Houwink AP; Schmidt S; Van Dongen EP; Hazebroek EJ; van Ramshorst B; Deneer VH; Mouton JW; Knibbe CA
J Antimicrob Chemother; 2014 Mar; 69(3):715-23. PubMed ID: 24214905
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
[TBL] [Abstract][Full Text] [Related]
11. Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass--a microdialysis study.
Mand'ák J; Pojar M; Maláková J; Lonsk V; Palicka V; Zivný P
Perfusion; 2007 Mar; 22(2):129-36. PubMed ID: 17708162
[TBL] [Abstract][Full Text] [Related]
12. In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery.
Hutschala D; Skhirtladze K; Kinstner C; Mayer-Helm B; Müller M; Wolner E; Tschernko EM
Ann Thorac Surg; 2007 Nov; 84(5):1605-10. PubMed ID: 17954069
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass.
Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C
Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208
[TBL] [Abstract][Full Text] [Related]
14. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
[TBL] [Abstract][Full Text] [Related]
15. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.
Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA
Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
[TBL] [Abstract][Full Text] [Related]
17. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery.
Asada M; Nagata M; Mizuno T; Uchida T; Kurashima N; Takahashi H; Makita K; Arai H; Echizen H; Yasuhara M
Pharmacol Res Perspect; 2018 Dec; 6(6):e00440. PubMed ID: 30410768
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of cefazolin in pediatric patients undergoing cardiac surgery.
Lapmahapaisan S; Maisat W; Tantiwongkosri K; Jutasompakorn P; Sisan W
Ann Card Anaesth; 2021; 24(2):149-154. PubMed ID: 33884969
[TBL] [Abstract][Full Text] [Related]
19. Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients.
Roberts JA; Udy AA; Jarrett P; Wallis SC; Hope WW; Sharma R; Kirkpatrick CM; Kruger PS; Roberts MS; Lipman J
J Antimicrob Chemother; 2015 May; 70(5):1495-502. PubMed ID: 25608584
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.
Young OM; Shaik IH; Twedt R; Binstock A; Althouse AD; Venkataramanan R; Simhan HN; Wiesenfeld HC; Caritis SN
Am J Obstet Gynecol; 2015 Oct; 213(4):541.e1-7. PubMed ID: 26103528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
